Literature DB >> 31025262

Impact of adrenomedullin blockage on lipid metabolism in female mice exposed to high-fat diet.

Yuanlin Dong1, Nicola van der Walt1, Kathleen A Pennington1, Chandra Yallampalli2.   

Abstract

PURPOSE: Adrenomedullin (ADM) levels are elevated in gestational and type 2 diabetic patients. ADM also stimulates lipolysis in vitro. Disturbed lipid metabolism has been implicated in the pathogenesis of diabetes. Here, we explore whether blockade of ADM is beneficial for metabolic homeostasis in a diabetic mouse model.
METHODS: C57BL/6J female mice were placed on either a control or a high fat high sucrose (HFHS) diet for 8 weeks. At week 4, osmotic mini-pumps were implanted for constant infusion of either saline or ADM antagonist, ADM22-52. Glucose tolerance tests were performed prior to infusion and 4 weeks after infusion began. Animals were then sacrificed and visceral adipose tissue collected for further analysis.
RESULTS: Mice fed HFHS displayed glucose intolerance, increased mRNA expressions in VAT for Adm and its receptor components, Crlr. HFHS fed mice also had increased basal and isoprenaline-induced glycerol release by VAT explants. ADM22-52 did not significantly affect glucose intolerance. ADM22-52 did suppress basal and isoprenaline-induced glycerol release by VAT explants. This alteration was associated with enhanced mRNA expression of insulin signaling factors Insr and Glut4, and adipogenic factor Pck1.
CONCLUSIONS: HFHS diet induces glucose intolerance and enhances ADM and its receptor expressions in VAT in female mice. ADM22-52 treatment did not affect glucose intolerance in HFHS mice, but reduced both basal and isoprenaline-induced lipolysis, which is associated with enhanced expression of genes involved in adipogenesis. These results warrant further research on the effects of ADM blockade in improving lipid homeostasis in diabetic patients.

Entities:  

Keywords:  Adrenomedullin; Diabetes; Lipid metabolism

Mesh:

Substances:

Year:  2019        PMID: 31025262      PMCID: PMC6901288          DOI: 10.1007/s12020-019-01927-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  Effect of food restriction and leptin supplementation on fetal programming in mice.

Authors:  Kathleen A Pennington; Jennifer L Harper; Ashley N Sigafoos; Lindsey M Beffa; Stephanie M Carleton; Charlotte L Phillips; Laura C Schulz
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 2.  The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.

Authors:  K Schoonjans; B Staels; J Auwerx
Journal:  Biochim Biophys Acta       Date:  1996-07-26

3.  Expression of the adrenomedullin gene in adipose tissue.

Authors:  Takuo Nambu; Hiroshi Arai; Yasato Komatsu; Akihiro Yasoda; Kenji Moriyama; Naotetsu Kanamoto; Hiroshi Itoh; Kazuwa Nakao
Journal:  Regul Pept       Date:  2005-09-08

4.  Pregnancy Increases Relaxation in Human Omental Arteries to the CGRP Family of Peptides.

Authors:  Yuanlin Dong; Ancizar Betancourt; Madhu Chauhan; Meena Balakrishnan; Fernando Lugo; Matthew L Anderson; Jimmy Espinoza; Karin Fox; Michael Belfort; Chandrasekhar Yallampalli
Journal:  Biol Reprod       Date:  2015-10-28       Impact factor: 4.285

5.  Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.

Authors:  Masahiro Ohira; Yoh Miyashita; Mariko Ebisuno; Atsuhito Saiki; Kei Endo; Nobukiyo Koide; Tomokazu Oyama; Takeyoshi Murano; Hitoshi Watanabe; Kohji Shirai
Journal:  Diabetes Res Clin Pract       Date:  2007-03-19       Impact factor: 5.602

Review 6.  Caveolae, lipid droplets, and adipose tissue biology: pathophysiological aspects.

Authors:  Sally Martin
Journal:  Horm Mol Biol Clin Investig       Date:  2013-09

Review 7.  Adrenomedullin, a multifunctional regulatory peptide.

Authors:  J P Hinson; S Kapas; D M Smith
Journal:  Endocr Rev       Date:  2000-04       Impact factor: 19.871

Review 8.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 9.  Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.

Authors:  Chih-Hao Lee; Peter Olson; Ronald M Evans
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

10.  Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.

Authors:  K Kitamura; K Kangawa; M Kawamoto; Y Ichiki; S Nakamura; H Matsuo; T Eto
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

View more
  5 in total

1.  Adrenomedullin Improves Cardiac Remodeling and Function in Obese Rats with Hypertension.

Authors:  Pei Qian; Qian Wang; Fang-Zheng Wang; Hang-Bing Dai; Hong-Yu Wang; Qing Gao; Hong Zhou; Ye-Bo Zhou
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-06

2.  Adrenomedullin ameliorates palmitic acid-induced insulin resistance through PI3K/Akt pathway in adipocytes.

Authors:  Hang-Bing Dai; Hong-Yu Wang; Fang-Zheng Wang; Pei Qian; Qing Gao; Hong Zhou; Ye-Bo Zhou
Journal:  Acta Diabetol       Date:  2022-01-03       Impact factor: 4.087

3.  Brief high fat high sugar diet results in altered energy and fat metabolism during pregnancy in mice.

Authors:  Kathleen A Pennington; Yuanlin Dong; Simone Hernandez Ruano; Nicola van der Walt; Haleh Sangi-Haghpeykar; Chandrasekhar Yallampalli
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

4.  Endoglin and Activin Receptor-like Kinase 1 (Alk1) Modify Adrenomedullin Expression in an Organ-Specific Manner in Mice.

Authors:  Josune García-Sanmartín; Judit Narro-Íñiguez; Alicia Rodríguez-Barbero; Alfredo Martínez
Journal:  Biology (Basel)       Date:  2022-02-24

5.  Adrenomedullin Attenuates Inflammation in White Adipose Tissue of Obese Rats Through Receptor-Mediated PKA Pathway.

Authors:  Hang-Bing Dai; Fang-Zheng Wang; Ying Kang; Jing Sun; Hong Zhou; Qing Gao; Zhen-Zhen Li; Pei Qian; Guo-Qing Zhu; Ye-Bo Zhou
Journal:  Obesity (Silver Spring)       Date:  2020-09-28       Impact factor: 9.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.